Preview: Lexicon Pharmaceuticals’s Earnings

Lexicon Pharmaceuticals (NASDAQ:LXRX) is gearing up to announce its quarterly earnings on Tuesday, 2024-11-12. Here’s a quick overview of what investors should know before the release. Analysts are estimating that Lexicon Pharmaceuticals will report an…

Preview: Voyager Therapeutics’s Earnings

Voyager Therapeutics (NASDAQ:VYGR) is preparing to release its quarterly earnings on Tuesday, 2024-11-12. Here’s a brief overview of what investors should keep in mind before the announcement. Analysts expect Voyager Therapeutics to report an earnings …

Earnings Outlook For Mirum Pharmaceuticals

Mirum Pharmaceuticals (NASDAQ:MIRM) is preparing to release its quarterly earnings on Tuesday, 2024-11-12. Here’s a brief overview of what investors should keep in mind before the announcement. Analysts expect Mirum Pharmaceuticals to report an earning…

Earnings Outlook For FibroGen

FibroGen (NASDAQ:FGEN) will release its quarterly earnings report on Tuesday, 2024-11-12. Here’s a brief overview for investors ahead of the announcement. Analysts anticipate FibroGen to report an earnings per share (EPS) of $-0.30. The announcement fr…

Unveiling 5 Analyst Insights On Netstreit

Netstreit (NYSE:NTST) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the…

Where Victory Capital Holdings Stands With Analysts

In the last three months, 8 analysts have published ratings on Victory Capital Holdings (NASDAQ:VCTR), offering a diverse range of perspectives from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the …